News

Researchers analysed 19 international youth gatherings and found nearly 70% of reported emergencies were infectious outbreaks, with foodborne illness also common. The study outlines measures to prevent illness at large events.

New study suggests that early-infancy infection with respiratory syncytial virus (RSV) may significantly increase the risk of developing childhood asthma. Protecting newborns against RSV could substantially reduce asthma cases later in life.

mRNA therapy encoding antimicrobial peptibodies reduces drug-resistant pneumonia severity in preclinical models and boosts immune defense.

Year-round RSV immunization could curb large seasonal outbreaks nationwide, reducing hospitalization risks across urban and rural communities.

UCLA’s CAR-NKT therapy overcomes solid-tumor barriers, eliminating primary and metastatic pancreatic cancer in advanced preclinical models.

A new study outlines that most of the benefits of hormone therapy for prostate cancer occur in the first 9 to 12 months, and extending therapy increases the risk of health problems.

Three-year-old Ollie Chu, born with the rare and life-limiting Hunter syndrome, is showing improvement after receiving an experimental stem cell gene therapy developed at the University of Manchester.

Researchers have developed a calcium-activated delivery system that improves how antibody–drug conjugates penetrate tumor cells.

Researchers at the Icahn School of Medicine at Mount Sinai have discovered how to reverse aging in blood-forming stem cells in mice by correcting defects in the stem cell’s lysosomes.

An experimental vaccine for a rare form of liver cancer that primarily affects children and young adults has shown early promise in a phase 1 clinical trial.